All about the 1st Covid-19 vaccine registered in Russia
Preclinical tests of the vaccine for toxicity, safety, immunogenicity and protective effectiveness on large and small animals were conducted at the 48th Central Research Institute of the Russian Ministry of Defence.
On June 16, the Russian Health Ministry issued a permit to conduct clinical trials of the vaccine on volunteers at the Burdenko Main Military Clinical Hospital.
Clinical trials of the vaccine started on June 18 and included 38 volunteers.
The volunteers were divided into two main groups – one group consisted of 18 people and the other group had 20.
The experiment started with the first group. Nine volunteers were given one component of the vaccine, and nine more were given the second component.
After receiving initial data on the safety and tolerability of the vaccine based on the results of the survey of the first group of volunteers, the vaccine was inserted into 20 more selected volunteers on June 23.